SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-007302
Filing Date
2020-04-29
Accepted
2020-04-29 06:18:15
Documents
11
Period of Report
2020-04-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 35106
2 ex99-1.htm EX-99.1 7472
3 ex99-1_001.jpg GRAPHIC 288816
4 ex99-1_002.jpg GRAPHIC 332195
5 ex99-1_003.jpg GRAPHIC 266926
6 ex99-1_004.jpg GRAPHIC 349952
7 ex99-1_005.jpg GRAPHIC 301702
8 ex99-1_006.jpg GRAPHIC 276192
9 ex99-1_007.jpg GRAPHIC 322852
10 ex99-1_008.jpg GRAPHIC 354331
11 ex99-1_009.jpg GRAPHIC 322488
  Complete submission text file 0001493152-20-007302.txt   3922390
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 20827192
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences